---
title: "Orforglipron vs Tirzepatide: Side-by-Side Comparison (2026)"
url: https://www.bodyhackguide.co/compare/orforglipron-vs-tirzepatide
description: "Compare Orforglipron vs Tirzepatide side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices."
lang: en
---

Skip to content

Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide)

# Orforglipron vs Tirzepatide

Side-by-side comparison of Orforglipron and Tirzepatide: mechanism, half-life, dose range, safety profile, and vendor pricing.

Orforglipron from $249.99

Tirzepatide from $49.00

## Price snapshot

### Orforglipron

Current low

$249.99

current listings

7-day low

—

not enough history yet

30-day low

—

not enough history yet

30-day change

—

not enough history yet

### Tirzepatide

Current low

$49.00

current listings

7-day low

—

not enough history yet

30-day low

—

not enough history yet

30-day change

—

not enough history yet

## Orforglipron

Orforglipron (also known as LY3502970) is Eli Lilly's oral, non-peptide, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, approved in the US for weight management and submitted to the FDA for type 2…

**Lowest listed price:** $249.99 across 1 listing

Full Orforglipron profile (https://www.bodyhackguide.co/compound/orforglipron)

## Tirzepatide

Featured

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with a molecular weight of 4813.45 Da and CAS number 2023788-19-2. It is a 39-amino-acid…

**Lowest listed price:** $49.00 across 14 listings

Full Tirzepatide profile (https://www.bodyhackguide.co/compound/tirzepatide)

## Side-by-side comparison

| Attribute | Orforglipron | Tirzepatide |
| --- | --- | --- |
| Category | Weight Loss | Metabolic & Weight Loss |
| Research Stage | FDA Approved | FDA Approved |
| Mechanism of Action | Orforglipron (LY3502970; OWL833) is an oral, non-peptide (small-molecule) GLP-1 receptor agonist. It engages the GLP-1 receptor (GLP1R) through a binding mode fundamentally different from native GLP-1 or peptide-based analogs. Non-Peptide Binding at a Distinct… | Dual GLP-1 and GIP Receptor Agonism Tirzepatide simultaneously activates two incretin receptors: the GLP-1 receptor and the GIP receptor. While the GLP-1 receptor component provides the well-established effects of GLP-1 agonism (glucose-dependent insulin… |
| Half-Life | ~29-49 hours (supports once-daily oral dosing) | ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification |
| Typical Dose Range | — | 2500 mcg (2.5 mg) starting dose, titrated every 4 weeks through 5000, 7500, 10000, 12500, to 15000 mcg (15 mg) maximum weekly dose |
| Dosing Frequency | Once daily | Once weekly subcutaneous injection |
| Administration | — | Subcutaneous (weekly) |
| Side Effects | Orforglipron's side effect profile closely mirrors the GLP-1 receptor agonist class as a whole, dominated by gastrointestinal effects that typically improve with continued dosing and proper titration. Common Gastrointestinal Effects (incidence 20-50% depending… | Mild to moderate nausea (especially at initiation), headache, fatigue, constipation or diarrhea, abdominal distension. Injection site reactions. Rare: hypoglycemia, increased heart rate, pancreatitis. |
| Molecular Weight | 882.97 g/mol | 4813.5 Da |
| Common Vial Sizes | — | 5mg, 10mg, 15mg |

## Price tracking

Tracking Orforglipron prices since April 6, 2026. Trend chart unlocks once we have price snapshots from more than one day.

## Price History

3 data points

- BM
- Half Nattys
- Ion Peptide

### Orforglipron: potential benefits

- No structured benefit list published.

### Tirzepatide: potential benefits

- Mean body weight reduction of 22.5% at 72 weeks - highest of any anti-obesity medication (PMID: 35658024)
- 36.2% of participants achieved greater than or equal to 25% body weight loss (PMID: 35658024)
- Significant HbA1c reduction in type 2 diabetes (up to 2.4% at 40 weeks in the SURPASS-5 add-on-to-insulin trial) (PMID: 35133415)
- Potentially superior lean mass preservation versus GLP-1-only agents due to GIP component
- Dual incretin mechanism providing complementary metabolic benefits
- Improved lipid profiles including triglycerides, LDL cholesterol, and HDL cholesterol
- Reduction in waist circumference and markers of visceral adiposity (PMID: 37840095)

## Frequently asked

### What's the difference between Orforglipron and Tirzepatide?

Orforglipron is a weight loss that orforglipron (ly3502970; owl833) is an oral, non-peptide (small-molecule) glp-1 receptor agonist. it engages the glp-1 receptor (glp1r) through a binding mode fundamentally…. Tirzepatide is a metabolic & weight loss that dual glp-1 and gip receptor agonism tirzepatide simultaneously activates two incretin receptors: the glp-1 receptor and the gip receptor. while the glp-1 receptor component…. The two differ in mechanism, half-life (~29-49 hours (supports once-daily oral dosing) vs ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification), and typical dose range.

### Which has the longer half-life, Orforglipron or Tirzepatide?

Orforglipron has a half-life of ~29-49 hours (supports once-daily oral dosing). Tirzepatide has a half-life of ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

### Which is cheaper, Orforglipron or Tirzepatide?

Lowest listed price on BodyHackGuide: Orforglipron from $249.99, Tirzepatide from $49.00. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.

### Can you stack Orforglipron and Tirzepatide?

Stacking depends on mechanism overlap, safety profile, and goals. Orforglipron and Tirzepatide should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

## See current vendor prices

Listings from the vendors we track. Prices change often, so check the vendor before you buy.

Orforglipron prices: https://www.bodyhackguide.co/compound/orforglipron?tab=prices

Tirzepatide prices: https://www.bodyhackguide.co/compound/tirzepatide?tab=prices

Compare all compounds: https://www.bodyhackguide.co/compare

### Before you buy Orforglipron or Tirzepatide

Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

View Vendor Scorecard (https://www.bodyhackguide.co/vendors/scorecard)

## Related comparisons

Retatrutide vs Tirzepatide: https://www.bodyhackguide.co/compare/retatrutide-vs-tirzepatide
Tirzepatide vs Semaglutide: https://www.bodyhackguide.co/compare/tirzepatide-vs-semaglutide
Mazdutide vs Tirzepatide: https://www.bodyhackguide.co/compare/mazdutide-vs-tirzepatide
Orforglipron vs Semaglutide: https://www.bodyhackguide.co/compare/orforglipron-vs-semaglutide
AOD-9604 vs Tirzepatide: https://www.bodyhackguide.co/compare/aod-9604-vs-tirzepatide
5-Amino-1MQ vs Tirzepatide: https://www.bodyhackguide.co/compare/5-amino-1mq-vs-tirzepatide

**Research use only.** BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards (https://www.bodyhackguide.co/editorial-standards) and affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure).

BodyHackGuide (https://www.bodyhackguide.co/)

Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews.

support@bodyhackguide.co

Join our Discord: https://discord.gg/Mhq5UdRYBA
r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide

**Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology). Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure).

**Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations.

© 2026 BodyHackGuide. All rights reserved.

- Terms: https://www.bodyhackguide.co/terms
- Privacy: https://www.bodyhackguide.co/privacy

## Structured data

```json
[
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {
        "@type": "ListItem",
        "position": 1,
        "name": "Home",
        "item": "https://www.bodyhackguide.co/"
      },
      {
        "@type": "ListItem",
        "position": 2,
        "name": "Compare",
        "item": "https://www.bodyhackguide.co/compare"
      },
      {
        "@type": "ListItem",
        "position": 3,
        "name": "Orforglipron vs Tirzepatide"
      }
    ]
  },
  {
    "@context": "https://schema.org",
    "@type": "WebPage",
    "name": "Orforglipron vs Tirzepatide: Side-by-Side Comparison (2026)",
    "description": "Compare Orforglipron vs Tirzepatide side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices.",
    "url": "https://www.bodyhackguide.co/compare/orforglipron-vs-tirzepatide",
    "dateModified": "2026-10-26",
    "isPartOf": {
      "@type": "WebSite",
      "name": "BodyHackGuide",
      "url": "https://www.bodyhackguide.co"
    },
    "mainEntity": {
      "@type": "ItemList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "item": {
            "@type": "Product",
            "name": "Orforglipron",
            "description": "Orforglipron (also known as LY3502970) is Eli Lilly's oral, non-peptide, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, approved in the US for weight management and submitted to the FDA for type 2 diabetes. Unlike virtually every other GLP-1 receptor agonist on the market…",
            "url": "https://www.bodyhackguide.co/compound/orforglipron",
            "category": "Weight Loss",
            "offers": {
              "@type": "AggregateOffer",
              "lowPrice": "249.99",
              "priceCurrency": "USD",
              "offerCount": 1
            }
          }
        },
        {
          "@type": "ListItem",
          "position": 2,
          "item": {
            "@type": "Product",
            "name": "Tirzepatide",
            "description": "Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with a molecular weight of 4813.45 Da and CAS number 2023788-19-2. It is a 39-amino-acid synthetic peptide based on the native GIP sequence with modifications that confer…",
            "url": "https://www.bodyhackguide.co/compound/tirzepatide",
            "category": "Metabolic & Weight Loss",
            "offers": {
              "@type": "AggregateOffer",
              "lowPrice": "49.00",
              "priceCurrency": "USD",
              "offerCount": 14
            }
          }
        }
      ]
    }
  },
  {
    "@context": "https://schema.org",
    "@type": "Organization",
    "@id": "https://www.bodyhackguide.co#organization",
    "name": "BodyHackGuide",
    "alternateName": "BHG",
    "url": "https://www.bodyhackguide.co",
    "logo": {
      "@type": "ImageObject",
      "url": "https://www.bodyhackguide.co/logo.png",
      "width": 512,
      "height": 512
    },
    "description": "Evidence-based research reference for peptides and nootropics. 273 compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.",
    "foundingDate": "2024",
    "founder": {
      "@id": "https://www.bodyhackguide.co/about#person"
    },
    "sameAs": [
      "https://reddit.com/r/BodyHackGuide",
      "https://reddit.com/r/BrainHackGuide",
      "https://reddit.com/r/Biohackingher",
      "https://discord.gg/Mhq5UdRYBA"
    ],
    "knowsAbout": [
      "Peptide research",
      "Nootropic research",
      "Biohacking",
      "Compound dosing",
      "Vendor transparency"
    ],
    "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards",
    "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards",
    "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards"
  },
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {
        "@type": "Question",
        "name": "What's the difference between Orforglipron and Tirzepatide?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Orforglipron is a weight loss that orforglipron (ly3502970; owl833) is an oral, non-peptide (small-molecule) glp-1 receptor agonist. it engages the glp-1 receptor (glp1r) through a binding mode fundamentally…. Tirzepatide is a metabolic & weight loss that dual glp-1 and gip receptor agonism tirzepatide simultaneously activates two incretin receptors: the glp-1 receptor and the gip receptor. while the glp-1 receptor component…. The two differ in mechanism, half-life (~29-49 hours (supports once-daily oral dosing) vs ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification), and typical dose range."
        }
      },
      {
        "@type": "Question",
        "name": "Which has the longer half-life, Orforglipron or Tirzepatide?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Orforglipron has a half-life of ~29-49 hours (supports once-daily oral dosing). Tirzepatide has a half-life of ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification. Longer half-lives generally mean less frequent dosing but slower on/off kinetics."
        }
      },
      {
        "@type": "Question",
        "name": "Which is cheaper, Orforglipron or Tirzepatide?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Lowest listed price on BodyHackGuide: Orforglipron from $249.99, Tirzepatide from $49.00. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers."
        }
      },
      {
        "@type": "Question",
        "name": "Can you stack Orforglipron and Tirzepatide?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Stacking depends on mechanism overlap, safety profile, and goals. Orforglipron and Tirzepatide should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds."
        }
      }
    ]
  }
]
```